Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 361 clinical trials
featured
Muscle-Invasive Bladder Cancer

People with bladder cancer are asked to participate in a research study being conducted by Northwell Health.  

  • 41 views
  • 23 Jan, 2020
  • 1 location
featured
Muscle- Invasive Bladder Cancer (MIBC)

People with bladder cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

  • 35 views
  • 30 Jan, 2020
  • 1 location
featured
KEYNOTE-676 (HRNMIBC) bladder cancer

People with bladder cancer are asked to participate in a research study being conducted by Northwell Health.  

  • 31 views
  • 22 Feb, 2019
  • 1 location
featured
BCG Naïve Non-Muscle Invasive Bladder Cancer

People with bladder cancer are asked to participate in a research study being conducted by Montefiore Medical Center.  

  • 13 views
  • 09 Jan, 2020
  • 1 location
featured
A Study to Evaluate INSTILADRIN® in Patients With High Grade, Bacillus Calmette-Guerin (BCG) Unresponsive NMIBC- Non muscle invasive bladder cancer

A Study to Evaluate INSTILADRIN® in Patients With High Grade, Bacillus Calmette-Guerin (BCG) Unresponsive NMIBC- Non muscle invasive bladder cancer

  • 142 views
  • 08 Nov, 2020
  • 1 location
featured
A multicenter clinical study of the Sonablate® 500 (Sonablate) for the TreAtment of locally Recurrent prostate cancer with HIFU(STAR Trial)

A multicenter clinical study of the Sonablate® 500 (Sonablate) for the TreAtment of locally Recurrent prostate cancer with HIFU(STAR Trial)

  • 196 views
  • 08 Nov, 2020
  • 1 location
Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer Patients

This is an open-label, randomized, multicentric study in patients with high-risk non-muscle invasive bladder cancer who had never received BCG for this disease. The objective is to

metastasis
transurethral resection
carcinoma
gilbert's syndrome
bladder tumor
  • 0 views
  • 24 Jan, 2021
  • 25 locations
Atezolizumab and BCG in High Risk BCG na ve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)

Patients with high-risk non-muscle invasive bladder cancer (NMIBC) are usually managed by transurethral resection of their bladder tumor (TURBT) alone plus additional intravesical therapy to

bacillus calmette-guerin
carcinoma in situ
carcinoma
transurethral resection
carcinoma of the bladder
  • 0 views
  • 25 Jan, 2021
Bempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid Tumors (PROPEL)

This study is to assess the safety and tolerability, and to assess the preliminary clinical benefit of NKTR-214 when combined with pembrolizumab (KEYTRUDA) with or without chemotherapy. The study is comprised of two groups; dose optimization and dose expansion cohorts. Dose Optimization will include first-line and second-line melanoma, non-small cell …

epidermal growth factor
immunologic adjuvant
pembrolizumab
pd-l1
squamous cell carcinoma of head and neck
  • 1682 views
  • 28 Feb, 2021
  • 66 locations
Study of CAbozantinib in Combination With AtezolizumaB for Muscle-Invasive BladdEr Cancer (ABATE)

This is an open-label phase II study assessing the activity of cabozantinib combined with atezolizumab in patients with resectable muscle-invasive urothelial carcinoma who are ineligible for cisplatin-based therapy or decline cisplatin-based therapy. Each cycle equals 21 days. The dose of atezolizumab is 1200 mg IV flat dose every 3 weeks …

transitional cell carcinoma
cancer
g-csf
white blood cell count
neutrophil count
  • 0 views
  • 28 Jan, 2021
  • 3 locations